Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 04:00PM ET
2.01
Dollar change
-0.01
Percentage change
-0.50
%
IndexRUT P/E- EPS (ttm)-1.35 Insider Own30.45% Shs Outstand39.11M Perf Week-4.29%
Market Cap87.84M Forward P/E- EPS next Y-1.92 Insider Trans0.00% Shs Float30.40M Perf Month-1.95%
Income-53.73M PEG- EPS next Q-0.41 Inst Own58.50% Short Float3.67% Perf Quarter-3.37%
Sales9.28M P/S9.47 EPS this Y-53.81% Inst Trans5.97% Short Ratio5.68 Perf Half Y-66.50%
Book/sh2.38 P/B0.84 EPS next Y-19.09% ROA-31.70% Short Interest1.12M Perf Year-5.41%
Cash/sh3.10 P/C0.65 EPS next 5Y10.90% ROE-48.27% 52W Range1.57 - 8.19 Perf YTD-47.93%
Dividend Est.- P/FCF- EPS past 5Y-13.31% ROI-38.54% 52W High-75.47% Beta0.46
Dividend TTM- Quick Ratio12.13 Sales past 5Y5.40% Gross Margin80.36% 52W Low27.74% ATR (14)0.17
Dividend Ex-Date- Current Ratio12.13 EPS Y/Y TTM-5.39% Oper. Margin-628.41% RSI (14)43.82 Volatility6.80% 7.72%
Employees47 Debt/Eq0.35 Sales Y/Y TTM-62.57% Profit Margin-578.80% Recom1.00 Target Price12.00
Option/ShortYes / Yes LT Debt/Eq0.34 EPS Q/Q-176.36% Payout- Rel Volume1.47 Prev Close2.02
Sales Surprise35.78% EPS Surprise-14.33% Sales Q/Q-85.86% EarningsAug 08 BMO Avg Volume196.48K Price2.01
SMA20-6.10% SMA50-7.75% SMA200-52.20% Trades Volume288,133 Change-0.50%
Date Action Analyst Rating Change Price Target Change
Apr-03-24Initiated JMP Securities Mkt Outperform $12
Aug-24-23Initiated Wedbush Outperform $9
Jun-06-23Resumed Jefferies Buy $11 → $12
Sep-10-21Initiated BofA Securities Buy $26
May-25-21Initiated SVB Leerink Outperform $29
May-25-21Initiated Jefferies Buy $22
May-25-21Initiated H.C. Wainwright Buy $32
May-25-21Initiated Evercore ISI Outperform $23
Sep-03-24 08:00AM
Aug-08-24 08:15AM
07:05AM
Jun-25-24 07:00AM
Jun-01-24 09:00AM
08:00AM Loading…
May-30-24 08:00AM
May-23-24 05:00PM
May-03-24 01:53PM
07:00AM
Apr-24-24 10:05AM
Apr-23-24 08:00AM
Apr-15-24 12:00PM
Apr-05-24 04:30PM
Apr-04-24 04:30PM
Mar-12-24 09:55AM
02:52PM Loading…
Mar-07-24 02:52PM
08:45AM
07:00AM
Mar-06-24 08:00AM
Mar-05-24 04:30PM
Jan-08-24 07:00AM
Jan-04-24 04:05PM
Nov-22-23 07:00AM
Nov-14-23 04:25PM
Nov-03-23 07:00AM
Oct-31-23 09:00AM
Oct-27-23 04:58AM
Sep-27-23 09:00AM
Sep-11-23 04:05PM
Sep-05-23 04:05PM
09:57AM Loading…
Aug-24-23 09:57AM
Aug-13-23 08:04AM
Aug-11-23 03:21PM
Aug-10-23 08:25AM
07:10AM
Jun-30-23 06:10AM
Jun-01-23 07:00AM
May-11-23 08:35AM
07:00AM
May-01-23 07:00AM
Apr-19-23 10:00AM
Mar-23-23 08:25AM
07:00AM
Mar-16-23 07:30AM
Mar-15-23 07:30AM
Feb-24-23 07:30AM
Feb-17-23 05:08AM
Feb-07-23 07:00AM
Jan-20-23 05:16AM
Dec-12-22 10:22AM
Nov-10-22 09:00AM
08:15AM
07:00AM
Nov-07-22 04:05PM
Sep-07-22 07:00AM
Sep-01-22 07:00AM
Aug-15-22 06:45AM
Aug-11-22 07:00AM
Aug-03-22 07:00AM
Jul-05-22 07:54AM
Jun-06-22 04:51PM
May-10-22 07:00AM
Apr-08-22 02:29PM
01:00PM
Apr-07-22 09:25AM
08:34AM
07:00AM
Mar-24-22 07:00AM
Mar-16-22 08:00AM
Mar-15-22 08:00AM
Feb-08-22 08:00AM
Jan-26-22 06:53AM
Jan-05-22 08:00AM
Dec-14-21 04:01PM
Dec-01-21 08:00AM
Nov-10-21 07:00AM
Nov-08-21 08:03AM
Oct-28-21 04:01PM
Oct-27-21 07:30AM
Sep-14-21 08:00AM
Sep-08-21 08:00AM
Aug-19-21 10:57AM
Aug-18-21 07:30AM
Aug-12-21 07:00AM
Jul-30-21 05:03AM
Jun-24-21 07:00AM
Jun-18-21 09:16PM
Jun-15-21 07:00AM
Jun-10-21 07:00AM
May-27-21 07:30AM
May-21-21 07:41PM
Apr-30-21 04:44PM
12:00PM
Apr-29-21 09:19PM
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation. The company was founded by Daniel J. Hicklin, Patrick A. Baeuerle, and Luke B. Evnin on October 19, 2017 and is headquartered in Watertown, MA.